Allegra Medical Technologies (ASX:AMT) 3-Year EPS without NRI Growth Rate : -18.60% (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Allegra Medical Technologies 3-Year EPS without NRI Growth Rate?

Allegra Medical Technologies's EPS without NRI for the six months ended in Dec. 2023 was A$-0.01.

During the past 3 years, the average EPS without NRI Growth Rate was -18.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was -27.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Allegra Medical Technologies was 58.30% per year. The lowest was -68.10% per year. And the median was 21.80% per year.

Competitive Comparison of Allegra Medical Technologies's 3-Year EPS without NRI Growth Rate

For the Medical Devices subindustry, Allegra Medical Technologies's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Allegra Medical Technologies's 3-Year EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Allegra Medical Technologies's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Allegra Medical Technologies's 3-Year EPS without NRI Growth Rate falls into.

Allegra Medical Technologies 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

Allegra Medical Technologies (ASX:AMT) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.

Allegra Medical Technologies 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Allegra Medical Technologies's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Allegra Medical Technologies (ASX:AMT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allegra Medical Technologies Ltd (ASX:AMT) » Definitions » 3-Year EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

18-20 Orion Road, Level 8, Lane Cove West, Sydney, NSW, AUS, 2066

Website

https://www.allegraorthopaedics.com

Allegra Medical Technologies Ltd is engaged in the research, product development, and manufacturing of medical devices including prosthetic implant tools. It offers adult and adolescent clavicle fixation systems and pins; shoulder implants; hand fracture plates and ulna heads, compression screws, distal radius systems, and hand fracture systems; hip stems and heads, CSF cups, and evolution and resurfacing hip products; and knee replacement systems among others. It operates in two segments Orthopaedics Division, which derives the majority of its revenue sells and distributes its portfolio of medical device products. Innovation Division which invests resources into the development and commercialization of new products to take to market.